You're reading the free version. Trader adds the live tape and alerts.
Start tracking
FDMT Sale Disclosure
Bizily Scott · SEC Form 4 · Filed Aug 17, 2026
Sale
Calculated transaction value
$19.62K
Bizily Scott Chief Legal Officer
FDMT
Transaction date
Aug 13, 2026
Public filing date
Aug 17, 2026
Filing lag
Filed 4 days later
FDMT daily price context
Close on/before transaction
$11.65
Aug 13, 2026
First close after public filing
$14.72
Aug 18, 2026
30-day return after filing
-6.52%
Through Sep 16, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 1,635 shares @ $12
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001193125-26-354313
Filing cohort
Transactions in this filing
Showing 6 of 6
Trades
6
Issuers
1
Estimated value
$53.1K
Buys / sales
0 / 2
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| 4d Molecular Therapeutics, Inc. FDMT | Sale | Aug 17, 2026 | $19.95K |
| 4d Molecular Therapeutics, Inc. FDMT | Exercise | Aug 17, 2026 | $6.77K |
| 4d Molecular Therapeutics, Inc. FDMT | Exercise | Aug 17, 2026 | $0 |
| 4d Molecular Therapeutics, Inc. FDMT | Exercise | Aug 13, 2026 | $6.77K |
| 4d Molecular Therapeutics, Inc. FDMT Current | Sale | Aug 13, 2026 | $19.62K |
| 4d Molecular Therapeutics, Inc. FDMT | Exercise | Aug 13, 2026 | $0 |